Original research
by
Gottlieb, Daniel J. et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
Our objective was to compare mortality rates for buprenorphine and methadone treatments among a large sample of US patients with OUD.
Findings/Key points
We found significantly lower all-cause mortality and suicide mortality rates for buprenorphine compared with methadone. Our results support the less restrictive prescribing practices for buprenorphine as OAT in the US.
Design/methods
US Department of Veterans Affairs data from 2010 through 2019.
Keywords
Mortality
Substitution/OAT
Outcomes
